r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

VT

Vuong Trieu

Insider · Chairman and CEO · OTLC

Vuong Trieu files insider transactions with the SEC as a chairman and ceo of Oncotelic Therapeutics (OTLC). We hold 6 disclosed purchases and sales filed since 31 October 2013, 6 of them in the last 90 days.

  • Files forOTLC
  • Disclosed buys and sells6 in all, 6 in the last 90 days
  • Last disclosure2 July 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 31 March 2021 — 10 July 2026Chairman and CEO · Oncotelic Therapeutics (OTLC)37 Form 4 lines · source: SEC Form 4
  • Filed 26 March 2020 — 19 November 2020Chief Executive Officer · Mateon Therapeutics (MATN)2 Form 4 lines · source: SEC Form 4
  • Filed 15 November 2016 — 1 October 2018Executive Chairman · Marina Biotech (MRNA)24 Form 4 lines · source: SEC Form 4
  • Filed 29 October 2013 — 29 October 2013Cso · Sorrento Therapeutics (SRNE)1 Form 4 line · source: SEC Form 4

Everything they disclosed

64 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.